Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KISS: Switching to Aripiprazole for Sexual Dysfunction in Schizophrenia
NCT02472652Phase 4Terminated
- Sponsor
- Thomas D. Gazda, M.D.
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by Thomas D. Gazda, M.D. Primary endpoint: Arizona Sexual Experiences Scale at 12 weeks. Started Jun 2015; status: terminated.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02472652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472652.